Carteol Monodose 1 % eye drops sol. single-dose cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

carteol monodose 1 % eye drops sol. single-dose cont.

viatris bv-srl - carteolol hydrochloride 10 mg/ml - eye drops, solution - 1 % - carteolol hydrochloride 10 mg/ml - carteolol

Carteol Monodose 2 % eye drops sol. single-dose cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

carteol monodose 2 % eye drops sol. single-dose cont.

viatris bv-srl - carteolol hydrochloride 20 mg/ml - eye drops, solution - 2 % - carteolol hydrochloride 20 mg/ml - carteolol

Arteoptic LA 2 % Eye drops, prolonged-release Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

arteoptic la 2 % eye drops, prolonged-release

orifarm - carteolol hydrochloride - eye drops, prolonged-release - 2 % - carteolol hydrochloride 20 mg/ml - carteolol

Teoptic 2% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teoptic 2% eye drops

thea pharmaceuticals ltd - carteolol hydrochloride - eye drops - 20mg/1ml

ocupress- carteolol hydrochloride solution United States - English - NLM (National Library of Medicine)

ocupress- carteolol hydrochloride solution

novartis ophthalmics - carteolol hydrochloride (unii: 4797w6i0t4) (carteolol - unii:8nf31401xg) - solution - ocupress ophthalmic solution, 1%, has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. it may be used alone or in combination with other intraocular pressure lowering medications. ocupress ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of this product.

FORTINOL LA 1 %w/v Eye Drops Prolonged Rel. Ireland - English - HPRA (Health Products Regulatory Authority)

fortinol la 1 %w/v eye drops prolonged rel.

chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 1 %w/v

FORTINOL LA 2 %w/v Eye Drops Prolonged Rel. Ireland - English - HPRA (Health Products Regulatory Authority)

fortinol la 2 %w/v eye drops prolonged rel.

chauvin pharmaceuticals limited - carteolol hydrochloride - eye drops prolonged rel. - 2 %w/v

TEOPTIC 1 %w/v Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

teoptic 1 %w/v eye drops solution

novartis pharmaceuticals uk ltd - carteolol hydrochloride - eye drops solution - 1 %w/v

TEOPTIC 2 %w/v Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

teoptic 2 %w/v eye drops solution

novartis pharmaceuticals uk ltd - carteolol hydrochloride - eye drops solution - 2 %w/v

Teoptic 1% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teoptic 1% eye drops

thea pharmaceuticals ltd - carteolol hydrochloride - eye drops - 10mg/1ml